EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Pharmacokinetics of sulbactam-durlobactam in patients with Acinetobacter baumannii ventriculitis: a report of two cases

Nazanin Pouya, Natalie A Finch, Alejandro Granillo, Adarsh Bhimraj, Vincent H Tam iD, William R Miller iD

Antimicrobial Agents and Chemotherapy · 05.11.2025 · 69 (11)

DOI: 10.1128/aac.00674-25 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.11.2025. Verfasst von Nazanin Pouya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Acinetobacter Infections, Anti-Bacterial Agents, Azabicyclo Compounds. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Two adult patients with ventriculitis due to Acinetobacter baumannii were treated with intravenous sulbactam-durlobactam as a part of a combination regimen. Penetration into the central nervous system was estimated (by cerebrospinal fluid [CSF]/serum area under the curve [AUC] ratios at steady state) for sulbactam (0.47–0.64) and durlobactam (0.27–0.3), respectively. In view of mostly constant CSF concentrations, single CSF levels at steady state may offer a more convenient and clinically applicable approach for monitoring therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsAzabicyclo CompoundsCerebral VentriculitisSulbactamAdultHumans

Stichwörter der Autor:innen

CNS penetrationbeta-lactambeta-lactamase inhibitorgram-negative bacteria

Substanzen

Anti-Bacterial AgentsAzabicyclo CompoundsdurlobactamSulbactam

Autor:innen und Institutionen

  • Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA.
  • Department of Pharmacy, Houston Methodist Hospital, Houston, Texas, USA.
  • Division of Infectious Diseases, Department of Internal Medicine, Houston Methodist Hospital, Houston, Texas, USA.

ORCID-Profile: Vincent H Tam, William R Miller

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Pouya, N., Finch, N. A., Granillo, A., Bhimraj, A., Tam, V. H., & Miller, W. R. (2025). Pharmacokinetics of sulbactam-durlobactam in patients with Acinetobacter baumannii ventriculitis: a report of two cases. Antimicrobial Agents and Chemotherapy, 69(11). https://doi.org/10.1128/aac.00674-25

Vancouver

Pouya N, Finch NA, Granillo A, Bhimraj A, Tam VH, Miller WR. Pharmacokinetics of sulbactam-durlobactam in patients with Acinetobacter baumannii ventriculitis: a report of two cases. Antimicrobial Agents and Chemotherapy. 2025;69(11). doi:10.1128/aac.00674-25

BibTeX
@article{Pouya2025,
  author = {Pouya, Nazanin and Finch, Natalie A and Granillo, Alejandro and Bhimraj, Adarsh and Tam, Vincent H and Miller, William R},
  title = {Pharmacokinetics of sulbactam-durlobactam in patients with Acinetobacter baumannii ventriculitis: a report of two cases},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  volume = {69},
  number = {11},
  doi = {10.1128/aac.00674-25}
}
Kostenlos starten →